Author:
Giuliani Silvia,Ciniselli Chiara Maura,Leonardi Elena,Polla Enzo,Decarli Nicola,Luchini Claudio,Cantaloni Chiara,Gasperetti Fabio,Cazzolli Daniela,Berlanda Gabriella,Bernardi Daniela,Pellegrini Marco,Triolo Renza,Ferro Antonella,Verderio Paolo,Barbareschi Mattia
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference24 articles.
1. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137
2. College of American Pathologist. ASCO/CAP HER2 test guideline recommendations: summary of guideline 2007 and 2013 Recommendations. 2013.
3. Wolff AC, Hammond ME, Hicks DG, et al. (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol 31:3997–4013
4. Wolff AC, Hammond ME, Schwartz JN, et al. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18–43
5. Slamon DJ, Clark GM, Wong SG, Lewin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182